Heart failure with preserved ejection fraction

[1] Abudiab MM(2013)Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction Eur J Heart Fail 15 776-785

[2] Redfield MM(2006)Effects of digoxin on morbidity and mortality in diastolic heart failure: the Ancillary Digitalis Investigation Group trial Circulation 114 397-403

[3] Melenovsky V(2013)Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial Circulation 127 1200-1208

[4] Olson TP(1997)Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or =40 % treated with diuretics plus angiotensin-converting enzyme inhibitors Am J Cardiol 80 207-209

[5] Kass DA(2012)Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 998-1005

[6] Johnson BD(2006)Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 260-269

[7] Borlaug BA(2010)cGMP enhancing therapy improves LV diastolic distensibility by phosphorylating titin Circulation 122 A8754-93

[8] Ahmed A(2010)Caveat medicus! Pulmonary hypertension in the elderly: a word of caution Eur J Heart Fail 12 89-781

[9] Rich MW(2005)Cardiomyocyte stiffness in diastolic heart failure Circulation 111 774-786

[10] Fleg JL(2009)Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium Circ Res 104 780-36

[1] Abudiab MM(2013)Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction Eur J Heart Fail 15 776-785

[2] Redfield MM(2006)Effects of digoxin on morbidity and mortality in diastolic heart failure: the Ancillary Digitalis Investigation Group trial Circulation 114 397-403

[3] Melenovsky V(2013)Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial Circulation 127 1200-1208

[4] Olson TP(1997)Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or =40 % treated with diuretics plus angiotensin-converting enzyme inhibitors Am J Cardiol 80 207-209

[5] Kass DA(2012)Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction J Am Coll Cardiol 59 998-1005

[6] Johnson BD(2006)Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 260-269

[7] Borlaug BA(2010)cGMP enhancing therapy improves LV diastolic distensibility by phosphorylating titin Circulation 122 A8754-93

[8] Ahmed A(2010)Caveat medicus! Pulmonary hypertension in the elderly: a word of caution Eur J Heart Fail 12 89-781

[9] Rich MW(2005)Cardiomyocyte stiffness in diastolic heart failure Circulation 111 774-786

[10] Fleg JL(2009)Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium Circ Res 104 780-36